Gleevec: A New Hope for Chronic Myeloid Leukaemia Patients

The video discusses chronic myeloid leukaemia (CML) and the revolutionary drug Gleevec, which allows patients to live normal lives without severe side effects. CML is linked to the Philadelphia chromosome, a genetic abnormality. Gleevec targets a faulty protein, preventing abnormal cell growth. It represents a new class of cancer drugs, offering hope to researchers and patients.

In what way does Gleevec target the faulty protein associated with CML?

What impact has Gleevec had on cancer research and patients?